Contraceptive Drugs and Devices Market surpassed USD 27 billion in 2021, owing to growing prevalence of sexually transmitted diseases (STDs) | insightSLICE
The global Contraceptive Drugs and Devices market size was estimated to be US$ 27 billion in 2021 and is expected grow at a CAGR of 5.9% between 2023 to 2032.
The rapid growth is mostly linked to increased public knowledge of reproductive health issues and government programs to address the world’s population expansion. In order to avoid unintended pregnancy and sexually transmitted diseases, the right contraceptive methods and medications must be used.
Access the sample report: https://www.insightslice.com/request-sample/291
The key players of the Global Contraceptive Drugs and Devices Market are:
ANI Pharmaceuticals, Inc., Merck & Co., Inc., Agile Therapeutics, Church & Dwight Co., Inc., Bayer AG, Mayer Laboratories, Inc., Pfizer Inc., Pantarhei Bioscience, Reckitt Benckiser Group plc, and Teva Pharmaceutical Industries Ltd. are major companies that dominate the global contraceptive drugs and devices market.
The report also takes the competitive environment into account, and as a result, it will provide company overviews and market forecasts for the top companies in the Contraceptive Drugs and Devices Market.
The report would also cover important advancements, global and regional company networks, business strategies, security and exchange overviews, R&D initiatives, production facilities, product portfolios, staff strength, and key executives for all the companies taken into account for the study.
For instance, the Bayer Group reported revenues of US$ 44,303.1 billion in 2018. According to the geographic analysis, the pharmaceuticals business segment accounted for the majority of the company’s revenue in 2018, with North America and Europe, the Middle East, and Africa (EMEA) accounting for the majority of its revenue generation.
Basic statistics present in this report:
This report will help in computing how much of the worldwide contraceptive medications and devices market every company in this sector. For example, the Bayer Group conducts business through four divisions: the Pharmaceuticals, Consumer Health, Crop Science, and Animal Health divisions.
The pharmaceutical business division of the company, which contributed the majority of the company’s revenue in 2018, provides contraceptive medications and devices.
The study takes into account essential competitive data from all the manufacturers of contraceptive medications and devices, including company strategy, product portfolio, key developments, SWOT analysis, and research and development priorities.
Read more about the report inclusions: https://www.insightslice.com/contraceptive-drugs-and-devices-market
The research of the worldwide market for contraceptive medications and devices will also analyze the role that each member plays in the market’s supply and value chains as well as their contribution.
All of the products in the company’s contraceptive medications and devices market business segment would serve as the main focus of the product portfolio segment of this report.
Similar to this, the current developments section will concentrate on the most recent business developments in the worldwide market for contraceptive drugs and devices, such as significant partnerships and alliances, mergers and acquisitions, newly released products, and global coverage.
Improved contraceptive pills and devices are a top priority for major players in the global market for contraceptive drugs and devices to stay competitive.
Major growth contributors based on region:
The most popular types of contraceptive techniques used by couples worldwide include tablets, condoms, long-acting reversible contraceptives (LARC), and female sterilization.
According to data from the Centers for Disease Control and Prevention, from 2015 to 2017, almost 65% of women between the ages of 15 and 49 utilized a contraceptive technique of some kind.
Due to a lack of access and understanding in African and Asian nations, the remaining 35% of women did not use any form of contraception. Manufacturers of contraceptive drugs and devices should find this to be a significant opportunity to grow their operations in Asia and Africa.
The market for contraceptive medications and devices is also expected to be driven by the increased prevalence of sexually transmitted illnesses over the forecast period.
Due to the high adoption of contraceptive pills and devices in the region, North America dominated the global market for contraceptive drugs and devices during the base year.
Additionally, government activities to increase awareness about the use of oral contraceptives and implants are predicted to be the most significant factor influencing the North American market for these products.
Due to government initiatives to improve reproductive safety and increased consumer knowledge of the usage of various contraceptive medications and technologies, the Asia Pacific region is predicted to experience the fastest market growth over the projection period.
Global Sleep Apnea Devices Market: https://www.insightslice.com/sleep-apnea-devices-market
Global Freeze Drying Market: https://www.insightslice.com/freeze-drying-market
Global Contraceptive Drugs and Devices Market Key Segments:
- Contraceptive Drugs
- Contraceptive Pills
- Contraceptive Devices
- Male Condoms
- Female Condoms
- Subdermal Implants
- Copper IUDs
- Hormonal IUDs
- Vaginal Rings
- North America
- United States
- Rest of North America
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- South America
- Rest of South America
Proceed to purchase: https://www.insightslice.com/buy-now/291
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at email@example.com.
+1 707 736 6633